Millipore Sigma Vibrant Logo

219401 Cathepsin D, Human Liver

219401
価格&在庫状況を照会

概要

Replacement Information

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
219401-15UCN
在庫状況検索中…
現在国内在庫なし
現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      樹脂アンプル 15 u
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      219401-30UCN
      在庫状況検索中…
      現在国内在庫なし
現在国内在庫なし
      現在国内在庫有り 
      販売中止
      在庫僅少
      現在国内在庫あり
        Remaining : Will advise
          Remaining : Will advise
          注文対象外
          お問合せください
          Contact Customer Service

          樹脂アンプル 30 u
          価格を検索中…
          価格が見つかりません
          Minimum Quantity needs to be mulitiple of
          Maximum Quantity is
          弊社照会 詳細を表示 
          値引
          ()
           
          弊社照会
          Description
          OverviewNative cathepsin D from human liver. A major lysosomal aspartyl protease produced as a 52 kDa proenzyme. Overexpression of cathepsin D in human breast cancers is associated with higher risk of relapse and metastasis. Cathepsin D degrades extracellular matrix and releases growth factors bound to the matrix.
          Catalogue Number219401
          Brand Family Calbiochem®
          References
          ReferencesBerchem, G., et al. 2002. Oncogene 21, 5951.
          Barbi, G.P., et al. 1994. Oncology 51, 329.
          Krishnan, V., et al. 1994. J. Biol. Chem. 269, 15912.
          Touitou, I., et al. 1994. Eur. J. Cancer 30A, 390.
          Rijnboutt, S., et al. 1991. J. Biol. Chem. 266, 23586.
          Johnson, G.V., et al. 1991. J. Neurochem. 57, 1577.
          Erickson, A. 1989. J. Cell. Biochem. 40, 31.
          Product Information
          CAS number9025-26-7
          Unit of DefinitionOne unit is defined as the amount of enzyme that will digest acid-denatured hemoglobin in 60 min, at 37°C, pH 3.3, releasing peptides soluble in 10% TCA, as measured by an increase in absorbance of 1.0 at 280 nm
          EC number3.4.23.5
          FormLyophilized
          FormulationLyophilized from 2 mM sodium phosphate buffer, pH 6.5.
          Quality LevelMQ100
          Applications
          Biological Information
          Purity≥90% by SDS-PAGE
          SourcePrepared from tissue of individuals that have been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
          Specific Activity≥300 units/mg protein
          Physicochemical Information
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Standard Handling
          Storage -20°C
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C) for long term storage or refrigerate (4°C) for short term storage. Stock solutions are stable for up to 1 week at 4°C. Keep on ice when working with material. When product is brought to its active pH (3.3), autolysis occurs.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications
          Global Trade Item Number
          カタログ番号 GTIN
          219401-15UCN 04055977201710
          219401-30UCN 04055977201727

          Documentation

          Cathepsin D, Human Liver 試験成績書(CoA)

          タイトルロット番号
          219401

          参考資料

          参考資料の概要
          Berchem, G., et al. 2002. Oncogene 21, 5951.
          Barbi, G.P., et al. 1994. Oncology 51, 329.
          Krishnan, V., et al. 1994. J. Biol. Chem. 269, 15912.
          Touitou, I., et al. 1994. Eur. J. Cancer 30A, 390.
          Rijnboutt, S., et al. 1991. J. Biol. Chem. 266, 23586.
          Johnson, G.V., et al. 1991. J. Neurochem. 57, 1577.
          Erickson, A. 1989. J. Cell. Biochem. 40, 31.

          カタログ

          タイトル
          Cathepsins and Related Products Technical Bulletin
          データシート

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision28-April-2008 RFH
          DescriptionNative cathepsin D from human liver. Degrades the extracellular matrix and releases growth factors bound to the matrix. Overexpression of cathepsin D in human breast cancers is associated with a higher risk of relapse and metastasis.
          FormLyophilized
          FormulationLyophilized from 2 mM sodium phosphate buffer, pH 6.5.
          SourcePrepared from tissue of individuals that have been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
          CAS number9025-26-7
          EC number3.4.23.5
          Purity≥90% by SDS-PAGE
          Specific activity≥300 units/mg protein
          Unit definitionOne unit is defined as the amount of enzyme that will digest acid-denatured hemoglobin in 60 min, at 37°C, pH 3.3, releasing peptides soluble in 10% TCA, as measured by an increase in absorbance of 1.0 at 280 nm
          SolubilitySterile H₂O or aqueous buffers. Please see vial label for lot-specific reconstitution volume.
          Storage -20°C
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C) for long term storage or refrigerate (4°C) for short term storage. Stock solutions are stable for up to 1 week at 4°C. Keep on ice when working with material. When product is brought to its active pH (3.3), autolysis occurs.
          Toxicity Standard Handling
          Merck USA index14, 1905
          ReferencesBerchem, G., et al. 2002. Oncogene 21, 5951.
          Barbi, G.P., et al. 1994. Oncology 51, 329.
          Krishnan, V., et al. 1994. J. Biol. Chem. 269, 15912.
          Touitou, I., et al. 1994. Eur. J. Cancer 30A, 390.
          Rijnboutt, S., et al. 1991. J. Biol. Chem. 266, 23586.
          Johnson, G.V., et al. 1991. J. Neurochem. 57, 1577.
          Erickson, A. 1989. J. Cell. Biochem. 40, 31.